↓ Skip to main content

Autologous stromal vascular fraction therapy for rheumatoid arthritis: rationale and clinical safety

Overview of attention for article published in International Archives of Medicine, February 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#24 of 103)
  • High Attention Score compared to outputs of the same age (82nd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

twitter
3 X users
patent
3 patents
facebook
4 Facebook pages

Citations

dimensions_citation
31 Dimensions

Readers on

mendeley
74 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Autologous stromal vascular fraction therapy for rheumatoid arthritis: rationale and clinical safety
Published in
International Archives of Medicine, February 2012
DOI 10.1186/1755-7682-5-5
Pubmed ID
Authors

Jorge Paz Rodriguez, Michael P Murphy, Soonjun Hong, Marialaura Madrigal, Keith L March, Boris Minev, Robert J Harman, Chien-Shing Chen, Ruben Berrocal Timmons, Annette M Marleau, Neil H Riordan

Abstract

Advancements in rheumatoid arthritis (RA) treatment protocols and introduction of targeted biological therapies have markedly improved patient outcomes, despite this, up to 50% of patients still fail to achieve a significant clinical response. In veterinary medicine, stem cell therapy in the form of autologous stromal vascular fraction (SVF) is an accepted therapeutic modality for degenerative conditions with 80% improvement and no serious treatment associated adverse events reported. Clinical translation of SVF therapy relies on confirmation of veterinary findings in targeted patient populations. Here we describe the rationale and preclinical data supporting the use of autologous SVF in treatment of RA, as well as provide 1, 3, 6, and 13 month safety outcomes in 13 RA patients treated with this approach.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 74 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 74 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 8 11%
Student > Ph. D. Student 4 5%
Student > Bachelor 2 3%
Professor 2 3%
Other 2 3%
Other 4 5%
Unknown 52 70%
Readers by discipline Count As %
Medicine and Dentistry 8 11%
Agricultural and Biological Sciences 3 4%
Biochemistry, Genetics and Molecular Biology 2 3%
Nursing and Health Professions 1 1%
Veterinary Science and Veterinary Medicine 1 1%
Other 4 5%
Unknown 55 74%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 January 2017.
All research outputs
#5,240,498
of 25,374,647 outputs
Outputs from International Archives of Medicine
#24
of 103 outputs
Outputs of similar age
#42,417
of 254,150 outputs
Outputs of similar age from International Archives of Medicine
#2
of 5 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 103 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.1. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 254,150 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 5 others from the same source and published within six weeks on either side of this one. This one has scored higher than 3 of them.